Thomas Engstrøm

Showing 1-19 of 19 articles

Coronary interventions

Myocardial Damage After ST-Segment Elevation Myocardial Infarction According to the Use of Bivalirudin or Heparin A Cardiac Magnetic Resonance Substudy of the DANAMI3 trial

Schoos MM, Nepper-Christensen L, Ahtarovski KA, Kyhl K, Goransson C, Holmvang L, Kelbæk H, Helqvist S, Høfsten D, Køber L, Vejlstrup N, Lønborg J, Engstrøm T

December 17, 2019 | 10.4244/EIJ-D-19-00623

Coronary interventions

Five-year clinical outcomes for the Resolute zotarolimus-eluting stent in total coronary occlusions

Kelbæk H, Yeh R, Engstrøm T, Neumann F, Serruys P, Windecker S, Belardi J, Qiao S, Xu B, Liu M, Silber S

November 20, 2019 | 10.4244/EIJ-D-19-00866

Coronary interventions

Fractional Flow Reserve Guided PCI in Patients With and Without Left Ventricular Hypertrophy: a DANAMI-3-PRIMULTI Sub-study

Sabbah M, Nepper-Christensen L, Lønborg J, Helqvist S, Køber L, Høfsten D, Ahtarovski K, Goransson C, Kyhl K, Schoos M, Vejlstrup N, Kelbæk H, Engstrøm T

November 20, 2019 | 10.4244/EIJ-D-19-00577

Coronary interventions

Selective intracoronary hypothermia in patients with ST-elevation myocardial infarction. Rationale and design of the EURO-ICE Trial.

El Farissi M, Keulards D, van 't Veer M, Zelis JM, Berry C, De Bruyne B, Engstrøm T, Fröbert O, Piroth Z, Oldroyd K, Tonino P, Pijls NH, Otterspoor L

September 10, 2019 | 10.4244/EIJ-D-19-00471

Characterisation of lesions undergoing ischaemia-driven revascularisation after complete revascularisation versus culprit lesion only in patients with STEMI and multivessel disease: a DANAMI-3-PRIMULTI substudy

De Backer O, Lønborg J, Helqvist S, Warnøe J, Kløvgaard L, Holmvang L, Pedersen F, Tilsted H, Raungaard B, Jørgensen E, Køber L, Høfsten D, Kelbæk H, Engstrøm T

June 20, 2019 | 10.4244/EIJ-D-18-00766

Coronary interventions

Intravascular assessment of coronary arteries in patients with cyanotic congenital heart disease

Tarp JB, Radu M, De Backer O, Jensen A, Celermajer D, Sorensen K, Holstein-Rathlou N-H, Engstrøm T, Søndergaard L

April 16, 2019 | 10.4244/EIJ-D-18-00882

Coronary interventions

Ten-year clinical outcome of patients treated with a drug-eluting stent in the proximal left anterior descending artery segment compared with patients stented in other non-left main coronary segments

Kjoller-Hansen L, Bligaard N, Kelbæk H, Christiansen E, Thuesen L, Hansen PR, Engstrøm T, Junker A, Abildgaard U, Flensted Lassen J, Jensen JS, Jeppesen JL, Galloe A

September 20, 2018 | 10.4244/EIJ-D-18-00396

STEMI

Impact of diagnostic ECG-to-wire delay in STEMI patients treated with primary PCI: a DANAMI-3 substudy

Nepper-Christensen L, Lønborg J, Hofsten D, Ahtarovski K, Kyhl K, Goransson C, Køber L, Helqvist S, Pedersen F, Kelbæk H, Vejlstrup N, Holmvang L, Engstrøm T

August 24, 2018 | 10.4244/EIJ-D-17-00857

Percutaneous coronary intervention in patients undergoing transcatheter aortic valve implantation: too early to draw conclusions

Lønborg J, Engstrøm T, De Backer O, Søndergaard L

August 3, 2018 | 10.4244/EIJV14I5A85

Coronary interventions

The Compare-Acute trial of fractional flow reserve-guided multivessel angioplasty in myocardial infarction

Chin C, L’Allier P, Neumann F, Engstrøm T, Jüni P, Olivecrona G

August 4, 2017 | 10.4244/EIJV13I5A96

Coronary interventions

To defer, or not to defer, that is the question

Kelbæk H, Hofsten D, Engstrøm T

July 20, 2017 | 10.4244/EIJV13I4A58

Coronary interventions

Intravenous beta-blocker therapy in ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention is not associated with benefit regarding short-term mortality: a Swedish nationwide observational study

Mohammad M, Andell P, Koul S, Desta L, Jernberg T, Omerovic E, Spaak J, Fröbert O, Jensen J, Engstrøm T, Hofman-Bang C, Persson H, Erlinge D

June 2, 2017 | 10.4244/EIJ-D-16-01021

Coronary interventions

Selective use of contemporary drug-eluting stents in primary angioplasty for ST-elevation myocardial infarction: pooled analysis of COMFORTABLE AMI and EXAMINATION

Baumbach A, Heg D, Räber L, Ostoijc M, Brugaletta S, Strange J, Johnson T, Jüni P, Engstrøm T, Serruys P, Sabaté M, Windecker S

January 20, 2017 | 10.4244/EIJ-D-15-00408

Coronary interventions

Bleeding episodes in “complete, staged” versus “culprit only” revascularisation in patients with multivessel disease and ST-segment elevation myocardial infarction: a DANAMI-3-PRIMULTI substudy

Sadjadieh G, Engstrøm T, Helqvist S, Hofsten D, Køber L, Pedersen F, Clemmensen P, Jørgensen E, Saunamäki K, Tilsted H, Kelbæk H, Holmvang L

November 20, 2016 | 10.4244/EIJV12I10A203

Coronary interventions

A post hoc analysis of long-term prognosis after exenatide treatment in patients with ST-segment elevation myocardial infarction

Kyhl K, Lønborg J, Vejlstrup N, Kelbæk H, Helqvist S, Holmvang L, Jørgensen E, Saunamäki K, Bøtker H, Clemmensen P, Køber L, Treiman M, Engstrøm T

July 20, 2016 | 10.4244/EIJV12I4A78

Coronary interventions

Long-term outcome of FFR-guided PCI for stable coronary artery disease in daily clinical practice: a propensity score-matched landmark analysis

De Backer O, Biasco L, Lønborg J, Pedersen F, Holmvang L, Kelbæk H, Arnous S, Saunamäki K, Helqvist S, Kastrup J, Jørgensen E, Engstrøm T

February 12, 2016 | 10.4244/EIJV11I11A247

Optimal catchment area and primary PCI centre volume revisited: a single-centre experience in transition from high-volume centre to “mega centre” for patients with ST-segment elevation myocardial infarction

Schoos M, Pedersen F, Holmvang L, Engstrøm T, Saunamäki K, Helqvist S, Kastrup J, Mehran R, Dangas G, Jørgensen E, Kelbæk H, Clemmensen P

September 22, 2015 | 10.4244/EIJY14M11_07

ST peak during percutaneous coronary intervention serves as an early prognostic predictor in patients with ST-segment elevation myocardial infarction

Lønborg J, Kelbæk H, Engstrøm T, Helqvist S, Kløvgaard L, Holmvang L, Vejlstrup N, Jørgensen E, Saunamäki K, Dridi N, Kaltoft A, Bøtker H, Clemmensen P, Terkelsen C

August 19, 2014 | 10.4244/EIJV10I4A80

Deferred stent implantation in patients with ST-segment elevation myocardial infarction: a pilot study

Kelbæk H, Engstrøm T, Ahtarovski K, Lønborg J, Vejlstrup N, Pedersen F, Holmvang L, Helqvist S, Saunamäki K, Jørgensen E, Clemmensen P, Kløvgaard L, Tilsted H, Raungaard B, Ravkilde J, Aaroe J, Eggert S, Køber L

February 22, 2013 | 10.4244/EIJV8I10A175

1

Latest news

"Shocktopics” with intravascular lithotripsy, bioprosthetic valve fracture, myocardial fibrosis in TAVI...

Reimaged models and angiograms showing CO March 17, 2020

New ahead of print: Infolding of self expanding valve during transcatheter aortic valve implantation

Nandhakumar Vasu et al

Bioresorbable scaffolds and STEMI: an ideal setting, but still vacant

Christian Spaulding

New Update: CULPRIT, NOBEL, IVUS-XPL, SAFARI-STEMI

(supported by Biotronik)

February 14, 2020

Guidance Papers

Guidelines, consensus & position papers

Defining procedural MI - does it matter (spoiler alert - it does!)

This week’s JAA’s: QFR in severe AS & Infection control for TAVI

Coronary

Valvular disease

Heart failure

Peripheral

Hypertension

Stroke